Résultats de votre recherche
-
7 Résultats
-
Perry Nisen - Executive Partner, Private Equity - has a PhD in Medicine from Albert Einstein College of Medicine of Yeshiva University and Bachelor of Science in Medical Microbiology from Stanford University.Sofinnova Investments - Fond - Etats—Unis
-
Perry Nisen - Chief Executive Officer and Director - has a PhD in Medicine from Albert Einstein College of Medicine of Yeshiva University and Bachelor of Science in Medical Microbiology from Stanford University.Quanta Therapeutics - Biotechnologie - Etats—Unis
-
Noreen Henig - Director - has a MD Distinction in Immunology from Albert Einstein College of Medicine of Yeshiva University and BA History of Art from Yale University.Avidity Biosciences - Biotechnologie - Etats—Unis
-
Mollie Ranalletta - Vice President, Head of Project Management, Deerfield Discovery and Development - has a Doctor of Philosophy in Biochemistry from Albert Einstein College of Medicine of Yeshiva University and Master of Science in Animal Science from Purdue University.Deerfield - Fond - Etats—Unis
-
Jeffrey Silber - Chief Medical Officer - has a Doctor of Medicine from Albert Einstein College of Medicine of Yeshiva University and Bachelor of Science in Biology from Harvard University.Vedanta Biosciences - Biotechnologie - Etats—Unis
-
Theodore Feldman - Chief Medical Officer - a reçu un Doctor of Medicine de Albert Einstein College of Medicine of Yeshiva University.Rightway Healthcare - Biotechnologie - Etats—Unis